Pediatric melanoma: An opportunity for psychosocial research - 24/04/13
Doi : 10.1016/j.jaad.2009.07.017
Jennifer L. Schwartz, MD a, ⁎ 
, Eileen Mollen, PhD b, Mathew W. Ludgate, MBChB a, Michelle B. Riba, MD c, Timothy M. Johnson, MD a
, Eileen Mollen, PhD b, Mathew W. Ludgate, MBChB a, Michelle B. Riba, MD c, Timothy M. Johnson, MD a a Department of Dermatology, University of Michigan Medical School and Comprehensive Cancer Center, Ann Arbor, Michigan
b Department of Pediatrics and Communicable Diseases, University of Michigan Medical School and Comprehensive Cancer Center, Ann Arbor, Michigan
c Department of Psychiatry, University of Michigan Medical School and Comprehensive Cancer Center, Ann Arbor, Michigan
Correspondence to: Jennifer L. Schwartz, MD, Department of Dermatology, University of Michigan Health System, 1910 Taubman Center, 1500 E Medical Center Dr, Ann Arbor, MI 48109-0314| Funding sources: None. |
|
| Conflicts of interest: None declared. |
© 2010
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 62 - N° 5
P. 892-893 - mai 2010 Retour au numéro
Article précédent
- Clofazimine, an antimycobacterial with potent in vitro and in vivo leishmanicidal activity, is ineffective against cutaneous Leishmania major infection in humans
- Mohammad Reza Namazi, Ladan Dastgheib, Jaber Mazandarani, Farideh Jowkar
- Pitfalls in the dermoscopic diagnosis of amelanotic melanoma
- Maria A. Pizzichetta, Vincenzo Canzonieri, Samuele Massarut, Tanja Baresic, Eugenio Borsatti, Scott W. Menzies
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?